Your browser is no longer supported. Please, upgrade your browser.
PRTK Paratek Pharmaceuticals, Inc. daily Stock Chart
PRTK [NASD]
Paratek Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-3.50 Insider Own4.30% Shs Outstand41.64M Perf Week1.14%
Market Cap183.90M Forward P/E- EPS next Y-0.59 Insider Trans-3.55% Shs Float38.97M Perf Month0.45%
Income-120.80M PEG- EPS next Q0.06 Inst Own47.00% Short Float10.94% Perf Quarter-7.11%
Sales22.90M P/S8.03 EPS this Y-10.20% Inst Trans-15.72% Short Ratio5.94 Perf Half Y50.76%
Book/sh-1.33 P/B- EPS next Y69.00% ROA-47.60% Target Price- Perf Year13.85%
Cash/sh4.70 P/C0.94 EPS next 5Y- ROE323.90% 52W Range2.50 - 5.89 Perf YTD10.17%
Dividend- P/FCF- EPS past 5Y12.90% ROI-52.40% 52W High-24.62% Beta1.51
Dividend %- Quick Ratio5.00 Sales past 5Y30.70% Gross Margin79.20% 52W Low77.60% ATR0.28
Employees102 Current Ratio5.30 Sales Q/Q393.80% Oper. Margin- RSI (14)57.37 Volatility6.61% 6.83%
OptionableYes Debt/Eq- EPS Q/Q39.80% Profit Margin- Rel Volume0.33 Prev Close4.30
ShortableYes LT Debt/Eq- EarningsMay 11 BMO Payout- Avg Volume717.52K Price4.44
Recom1.70 SMA202.26% SMA509.76% SMA20015.47% Volume233,451 Change3.26%
Jan-08-20Initiated WBB Securities Speculative Buy $6
Jan-02-19Initiated Canaccord Genuity Buy $14
Nov-23-18Reiterated H.C. Wainwright Buy $55 → $22
Aug-27-18Initiated BofA/Merrill Neutral $13
Mar-02-18Downgrade Raymond James Strong Buy → Outperform
Oct-24-17Initiated Guggenheim Buy $44
Jul-18-17Reiterated H.C. Wainwright Buy $36 → $43
May-19-17Initiated Raymond James Strong Buy
Apr-11-17Reiterated H.C. Wainwright Buy $33 → $36
Apr-04-17Reiterated Wedbush Outperform $30 → $34
Apr-04-17Initiated Wedbush Outperform $30
Oct-27-16Resumed Leerink Partners Outperform $23
Jun-17-16Reiterated H.C. Wainwright Buy $31 → $34
May-13-16Initiated Robert W. Baird Outperform $30
Mar-30-16Resumed Cantor Fitzgerald Buy $27
Feb-29-16Initiated H.C. Wainwright Buy $32
Jul-22-15Initiated Gabelli & Co Buy $34
May-15-15Initiated Leerink Partners Outperform
May-12-15Initiated Cantor Fitzgerald Buy $35
May-11-15Initiated Guggenheim Buy $38
May-29-20 08:30AM  Paratek Pharmaceuticals Announces Change to Time of 2020 Annual Meeting of Stockholders GlobeNewswire
May-28-20 08:00AM  Paratek Pharmaceuticals to Present at Jefferies 2020 Virtual Healthcare Conference GlobeNewswire
May-11-20 04:05PM  Paratek Pharmaceuticals to Present at Bank of America Securities 2020 Health Care Conference GlobeNewswire
07:55AM  Paratek Pharmaceuticals (PRTK) Reports Q1 Loss, Tops Revenue Estimates Zacks
07:14AM  Paratek Pharmaceuticals: Q1 Earnings Insights Benzinga
06:30AM  Paratek Pharmaceuticals Announces First Quarter 2020 Total Revenues of $7.9 Million including NUZYRA® (omadacycline) Net Sales of $7.3 Million GlobeNewswire
Apr-30-20 08:00AM  Paratek Pharmaceuticals to Report First Quarter 2020 Financial Results on May 11, 2020 GlobeNewswire -7.47%
Apr-28-20 12:14PM  Will Paratek Pharmaceuticals Continue to Surge Higher? Zacks
Apr-14-20 12:26PM  Seth Klarman Dials Down Akebia Therapeutics Stake GuruFocus.com
Apr-02-20 08:00AM  Paratek Pharmaceuticals Announces Initiation of Funding from BARDA for All FDA Required Post-marketing Studies for NUZYRA (omadacycline) GlobeNewswire
Apr-01-20 08:00AM  Paratek Pharmaceuticals Announces Initiation of Funding from BARDA for Security Requirements and U.S. Onshoring of the Manufacturing Supply Chain for NUZYRA (omadacycline) GlobeNewswire -5.71%
Mar-14-20 10:55AM  Paratek Pharmaceuticals, Inc. Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock? Simply Wall St.
Mar-10-20 05:12PM  Edited Transcript of PRTK earnings conference call or presentation 25-Feb-20 9:30pm GMT Thomson Reuters StreetEvents
04:01PM  Paratek Pharmaceuticals Announces the Submission of the pre-Emergency Use Authorization Application to the FDA for NUZYRA (omadacycline) GlobeNewswire
Mar-02-20 04:05PM  Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Feb-27-20 11:50AM  Paratek Pharmaceuticals, Inc. Just Reported Yearly Earnings And Analysts Are Lifting Their Estimates Simply Wall St.
Feb-26-20 08:00AM  Paratek Pharmaceuticals to Present at the SVB Leerink 9th Annual Global Healthcare Conference GlobeNewswire +20.00%
Feb-25-20 05:35PM  Paratek Pharmaceuticals (PRTK) Reports Q4 Loss, Tops Revenue Estimates Zacks
04:01PM  Paratek Pharmaceuticals Announces Full Year 2019 Total Revenues of $16.5 Million including NUZYRA® (omadacycline) Net Sales of $11.5 Million GlobeNewswire
Feb-24-20 07:00AM  Paratek Announces License Grant to Almirall for SEYSARA® (sarecycline) for Greater China Region GlobeNewswire
Feb-17-20 01:36PM  Is Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) A Volatile Stock? Simply Wall St.
Feb-13-20 04:01PM  Paratek Pharmaceuticals to Report Fourth Quarter and Full Year 2019 Financial Results on February 25, 2020 GlobeNewswire
Jan-14-20 03:12PM  Find Cheap Highly-Ranked Stocks Trading Under $10 for 2020 Zacks -5.33%
Dec-20-19 08:38AM  Are Options Traders Betting on a Big Move in Paratek Pharmaceuticals (PRTK) Stock? Zacks
Dec-19-19 09:33PM  Why this King of Prussia biopharma's stock rose 32% Thursday American City Business Journals +32.20%
08:53AM  Paratek's stock rockets on government contract MarketWatch
07:52AM  The Daily Biotech Pulse: Seattle Genetics' Bladder Cancer Drug Gets FDA Nod, Paratek Wins Contract For Antibiotic Benzinga
Dec-18-19 05:12PM  Paratek Awarded BARDA Project BioShield Contract for NUZYRA® GlobeNewswire
Dec-13-19 03:06PM  Is Paratek Pharmaceuticals Inc (PRTK) Going to Burn These Hedge Funds? Insider Monkey +5.48%
Dec-10-19 12:22PM  Seth Klarman Pares Paratek Pharmaceuticals Stake GuruFocus.com
Dec-06-19 08:00AM  12 Biotech Stocks Primed For A Short Squeeze Benzinga
Dec-02-19 04:05PM  Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Nov-30-19 11:02AM  Penny Stocks to Buy Using Technical Analysis for December 2019 Investopedia
Nov-28-19 06:59PM  Edited Transcript of PRTK earnings conference call or presentation 12-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Nov-13-19 12:14PM  Did Changing Sentiment Drive Paratek Pharmaceuticals's (NASDAQ:PRTK) Share Price Down A Painful 79%? Simply Wall St. -8.19%
Nov-12-19 05:15PM  Paratek Pharmaceuticals (PRTK) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:05PM  Paratek Pharmaceuticals Generates Net Revenues of $3.9 Million in the Third Quarter of 2019 GlobeNewswire
Nov-05-19 10:31AM  Analysts Estimate Paratek Pharmaceuticals (PRTK) to Report a Decline in Earnings: What to Look Out for Zacks +24.53%
Nov-04-19 04:05PM  Paratek Pharmaceuticals to Report Third Quarter 2019 Financial Results on November 12, 2019 GlobeNewswire
Nov-01-19 04:05PM  Paratek Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
07:38AM  The Daily Biotech Pulse: Amgen Takes 20.5% Stake In BeiGene, Paratek's Mixed Clinical Readout, CareDx Slips On Guidance Benzinga
Oct-31-19 04:05PM  Paratek Announces Top Line Results of Phase 2 Clinical Studies of Omadacycline in Urinary Tract Infections GlobeNewswire
Oct-29-19 10:32AM  Earnings Preview: Paratek Pharmaceuticals (PRTK) Q3 Earnings Expected to Decline Zacks
Oct-18-19 07:07AM  The Daily Biotech Pulse: Intuitive Surgical Earnings, Paratek Pulls Out European Application For Antibiotic, Amgen's Evenity In Europe Benzinga -6.36%
Oct-17-19 04:05PM  Paratek Withdraws European Marketing Authorization Application for Oral and Intravenous NUZYRA in Skin Infections and Pneumonia GlobeNewswire
Oct-01-19 04:30PM  Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
10:07AM  Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2019 PR Newswire
Sep-25-19 08:00AM  Paratek Pharmaceuticals Presenting New Data from NUZYRA® (Omadacycline) Development Program at IDWeek 2019 GlobeNewswire
Sep-24-19 08:50AM  Paratek Pharmaceuticals (PRTK) Catches Eye: Stock Jumps 10.2% Zacks
Sep-23-19 01:16PM  Seth Klarman Further Increases Translate Bio Stake GuruFocus.com +10.22%
Sep-10-19 01:58PM  Baupost's Seth Klarman Dives Further Into Translate Bio GuruFocus.com +9.57%
12:33PM  Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK): What Does Its Beta Value Mean For Your Portfolio? Simply Wall St.
Sep-09-19 08:00AM  Paratek Mourns Passing of Co-founder Dr. Stuart Levy GlobeNewswire +18.25%
Sep-04-19 08:00AM  Paratek Pharmaceuticals to Present at the 21st Annual H.C. Wainwright Global Investment Conference GlobeNewswire
Sep-03-19 04:05PM  Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Aug-30-19 01:31PM  Seth Klarman's Small Biotech Holdings GuruFocus.com +10.32%
08:00AM  The Lancet Infectious Diseases Publishes Results from Parateks Phase 3 Oral only Dosing Study of NUZYRA® (omadacycline) for Skin Infections GlobeNewswire
Aug-26-19 04:05PM  Paratek Pharmaceuticals to Present at Robert W. Bairds 2019 Global Healthcare Conference GlobeNewswire
Aug-13-19 02:07AM  Edited Transcript of PRTK earnings conference call or presentation 6-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-06-19 05:45PM  Paratek Pharmaceuticals (PRTK) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:05PM  Paratek Pharmaceuticals Generates Net Revenues of $2.0 Million in the Second Quarter of 2019 GlobeNewswire
Aug-01-19 04:05PM  Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Jul-29-19 04:05PM  Paratek Pharmaceuticals to Report Second Quarter 2019 Financial Results on August 6, 2019 GlobeNewswire
Jul-25-19 10:33AM  Earnings Preview: Paratek Pharmaceuticals (PRTK) Q2 Earnings Expected to Decline Zacks
Jul-17-19 04:02PM  Melinta (MLNT) Announces Preliminary Product Sales for Q2 Zacks -6.93%
Jul-10-19 07:00AM  What Type Of Shareholder Owns Paratek Pharmaceuticals, Inc.'s (NASDAQ:PRTK)? Simply Wall St.
Jul-05-19 03:59PM  Heres What Hedge Funds Think About Paratek Pharmaceuticals Inc (PRTK) Insider Monkey
Jul-01-19 09:13AM  X-Biotix Therapeutics Joins Antimicrobials Working Group PR Newswire
Jun-25-19 04:01PM  Paratek Pharmaceuticals Promotes Evan Loh, M.D. to Chief Executive Officer; Michael Bigham to Assume Role of Executive Chairman GlobeNewswire
Jun-20-19 11:48AM  Biotech companies dominate fastest-growing public companies list again American City Business Journals
11:13AM  Antimicrobials Working Group Highlights Member Company Participation at ASM Microbe 2019 PR Newswire
Jun-07-19 09:27AM  Antimicrobials Working Group Commends Senator Isakson and Senator Casey for Introducing Legislation to Improve Access to Innovative Therapies to Fight Drug-Resistant Infections PR Newswire
May-20-19 07:15AM  Edited Transcript of PRTK earnings conference call or presentation 8-May-19 8:30pm GMT Thomson Reuters StreetEvents -6.81%
May-08-19 05:25PM  Paratek Pharmaceuticals (PRTK) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:25PM  Paratek: 1Q Earnings Snapshot Associated Press
04:05PM  Parateks NUZYRA (omadacycline) Generates Net Sales of $1.3 Million in the First Eight Weeks on the U.S. Market GlobeNewswire
May-01-19 10:32AM  Analysts Estimate Paratek Pharmaceuticals (PRTK) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-30-19 04:05PM  Paratek Pharmaceuticals to Report First Quarter 2019 Financial Results on May 8, 2019 GlobeNewswire
Apr-20-19 09:27AM  Should You Be Pleased About The CEO Pay At Paratek Pharmaceuticals, Inc.'s (NASDAQ:PRTK) Simply Wall St.
Apr-15-19 04:30PM  Paratek Pharmaceuticals Broadens Clinical Profile of NUZYRA (Omadacycline) with New ECCMID 2019 Data Presentations GlobeNewswire -6.33%
Apr-12-19 10:08AM  Antimicrobials Working Group Highlights Member Company Participation at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) PR Newswire
Apr-04-19 08:30AM  Paratek Pharmaceuticals Presenting New Data from NUZYRA (Omadacycline) Development Program at ECCMID 2019 GlobeNewswire
Apr-01-19 09:05AM  Paratek Pharmaceuticals Receives American Chemical Society 2019 Heroes of Chemistry Award GlobeNewswire +5.41%
08:10AM  Market Trends Toward New Normal in Verizon Communications, Digital Turbine, Vericel, Capstead Mortgage, Paratek Pharmaceuticals, and CryoPort Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Mar-28-19 08:00AM  Paratek Pharmaceuticals to Present at the 2019 H.C Wainwright Global Life Sciences Conference GlobeNewswire
Mar-20-19 01:35PM  Seth Klarman's Small Caps: Worth a Look? GuruFocus.com
Mar-18-19 08:00AM  Paratek Pharmaceuticals Announces Management Change GlobeNewswire
Mar-07-19 12:47PM  What Should Investors Know About Paratek Pharmaceuticals, Inc.s (NASDAQ:PRTK) Future? Simply Wall St.
Mar-05-19 07:49PM  Edited Transcript of PRTK earnings conference call or presentation 27-Feb-19 9:30pm GMT Thomson Reuters StreetEvents
Mar-01-19 04:30PM  Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
08:00AM  Paratek Pharmaceuticals to Present at the Cowen and Company 39th Annual Health Care Conference GlobeNewswire
Feb-27-19 09:08PM  Paratek Pharmaceuticals Inc (PRTK) Q4 2018 Earnings Conference Call Transcript Motley Fool
04:01PM  Paratek Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire
Feb-20-19 10:31AM  Will Paratek Pharmaceuticals (PRTK) Report Negative Earnings Next Week? What You Should Know Zacks
Feb-14-19 04:05PM  Paratek Pharmaceuticals to Present at the 8th Annual SVB Leerink Global Healthcare Conference GlobeNewswire
Feb-13-19 04:05PM  Paratek Pharmaceuticals to Report Fourth Quarter and Full Year 2018 Financial Results on February 27, 2019 GlobeNewswire
Feb-06-19 05:05PM  New England Journal of Medicine Publishes Results from Pivotal Phase 3 Studies of Parateks NUZYRA (Omadacycline) For Pneumonia and Skin Infections GlobeNewswire
08:23AM  The Daily Biotech Pulse: Paratek Launches Antibiotic In US, Eli Lilly Earnings, Catabasis Offering Benzinga
Feb-05-19 04:05PM  Paratek Pharmaceuticals Launches NUZYRA (Omadacycline) in the United States GlobeNewswire
Feb-01-19 04:01PM  Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectrum antibiotic for the treatment of adult patients with community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections caused by susceptible pathogens; and SEYSARA, a tetracycline designed for the treatment of moderate to severe acne vulgaris. The company has license and collaboration agreements with Zai Lab (Shanghai) Co., Ltd. and Allergan plc; license agreement with Tufts University to develop and commercialize products for the treatment or prevention of bacterial or microbial diseases, or medical conditions; and cooperative research and development agreement with the U.S. Army Medical Research Institute of Infectious Diseases to study omadacycline against pathogenic agents causing infectious diseases. Paratek Pharmaceuticals, Inc. was founded in 1996 and is headquartered in Boston, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Haskel William M.Sr. VP, Sec. & General CounselMay 12Sale4.754,66622,164198,690May 14 06:42 PM
Brenner Randall B.Chief Development & RegulatoryMay 12Sale4.756,19829,441130,813May 14 06:38 PM
Woodrow AdamPresident & Chief CommercialMay 12Sale4.754,79822,791270,673May 14 06:30 PM
Loh EvanCEOMay 12Sale4.759,59545,576552,008May 14 06:27 PM
BIGHAM MICHAELExec. Chairman of the BoardMay 12Sale4.6812,25057,330542,167May 14 06:23 PM
Haskel William M.Sr. VP, Sec. & General CounselDec 12Sale3.102,8648,878158,356Dec 16 06:11 PM
Brenner Randall B.Chief Development & RegulatoryDec 12Sale3.106,27819,46292,011Dec 16 06:08 PM
Loh EvanCEODec 12Sale3.1014,51444,993417,603Dec 16 06:06 PM
Woodrow AdamPresident & Chief CommercialDec 12Sale3.104,40113,643207,971Dec 16 06:03 PM
Brenner Randall B.Chief Development & RegulatoryOct 08Sale3.825,04919,28798,289Oct 08 08:45 PM
Woodrow AdamPresident & Chief CommercialOct 08Sale3.825,32220,330212,372Oct 08 08:58 PM
Loh EvanCEOOct 08Sale3.827,81829,865432,117Oct 08 08:55 PM
Loh EvanCEOOct 03Sale3.9816,26564,735413,935Oct 07 05:13 PM
Brenner Randall B.Chief Development & RegulatoryOct 03Sale3.987,67430,54391,338Oct 07 05:10 PM